61 – 70 of 157
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
A retrospective analysis of health care costs for bone fractures in women with early-stage breast carcinoma
(
- Contribution to journal › Article
-
Mark
Epidemiology of osteoporosis and fracture in men
(
- Contribution to journal › Article
-
Mark
Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden.
(
- Contribution to journal › Article
-
Mark
Excess mortality after hospitalisation for vertebral fracture
(
- Contribution to journal › Article
-
Mark
Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden - An economic evaluation based on the MORE study
(
- Contribution to journal › Article
-
Mark
Raloxifene reduces risk of vertebral fractures and breast cancer in postmenopausal women regardless of prior hormone therapy.
(
- Contribution to journal › Article
-
Mark
Forearm bone mineral density in 1294 middle-aged women: a strong predictor of fragility fractures.
(
- Contribution to journal › Article
-
Mark
The risk and burden of vertebral fractures in Sweden
(
- Contribution to journal › Article
-
Mark
Risk factors for incident vertebral fractures in men and women: The Rotterdam study
(
- Contribution to journal › Article
-
Mark
Associations Between Baseline Risk Factors and Vertebral Fracture Risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study.
(
- Contribution to journal › Article